Effect of naltrexone on senile dementia of the Alzheimer type

Bradley T. Hyman, Paul J. Eslinger, Antonio R. Damasio

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Some reports have suggested that naloxone, a short-acting opiate receptor blocker given intravenously, has a beneficial effect on the symptoms of senile dementia of the Alzheimier type. We have performed a double-blind, crossover trial of naltrexone, an orally active, long acting opiate antagonist, in 17 Alzheimer-type dementia patients. None showed any improvement in assessments of day-to-day living skills or on a battery of neuropsychological tests. No side effects were noted. In the dosage used, naltrexone appears not to be useful in Alzheimer-type dementia.

Original languageEnglish (US)
Pages (from-to)1169-1171
Number of pages3
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume48
Issue number11
DOIs
StatePublished - Jan 1 1985

Fingerprint

Naltrexone
Alzheimer Disease
Opiate Alkaloids
Neuropsychological Tests
Opioid Receptors
Naloxone
Cross-Over Studies

All Science Journal Classification (ASJC) codes

  • Surgery
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this

Hyman, Bradley T. ; Eslinger, Paul J. ; Damasio, Antonio R. / Effect of naltrexone on senile dementia of the Alzheimer type. In: Journal of Neurology, Neurosurgery and Psychiatry. 1985 ; Vol. 48, No. 11. pp. 1169-1171.
@article{502b898c662c4723b2cd4dc1fc735b7f,
title = "Effect of naltrexone on senile dementia of the Alzheimer type",
abstract = "Some reports have suggested that naloxone, a short-acting opiate receptor blocker given intravenously, has a beneficial effect on the symptoms of senile dementia of the Alzheimier type. We have performed a double-blind, crossover trial of naltrexone, an orally active, long acting opiate antagonist, in 17 Alzheimer-type dementia patients. None showed any improvement in assessments of day-to-day living skills or on a battery of neuropsychological tests. No side effects were noted. In the dosage used, naltrexone appears not to be useful in Alzheimer-type dementia.",
author = "Hyman, {Bradley T.} and Eslinger, {Paul J.} and Damasio, {Antonio R.}",
year = "1985",
month = "1",
day = "1",
doi = "10.1136/jnnp.48.11.1169",
language = "English (US)",
volume = "48",
pages = "1169--1171",
journal = "Journal of Neurology, Neurosurgery and Psychiatry",
issn = "0022-3050",
publisher = "BMJ Publishing Group",
number = "11",

}

Effect of naltrexone on senile dementia of the Alzheimer type. / Hyman, Bradley T.; Eslinger, Paul J.; Damasio, Antonio R.

In: Journal of Neurology, Neurosurgery and Psychiatry, Vol. 48, No. 11, 01.01.1985, p. 1169-1171.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of naltrexone on senile dementia of the Alzheimer type

AU - Hyman, Bradley T.

AU - Eslinger, Paul J.

AU - Damasio, Antonio R.

PY - 1985/1/1

Y1 - 1985/1/1

N2 - Some reports have suggested that naloxone, a short-acting opiate receptor blocker given intravenously, has a beneficial effect on the symptoms of senile dementia of the Alzheimier type. We have performed a double-blind, crossover trial of naltrexone, an orally active, long acting opiate antagonist, in 17 Alzheimer-type dementia patients. None showed any improvement in assessments of day-to-day living skills or on a battery of neuropsychological tests. No side effects were noted. In the dosage used, naltrexone appears not to be useful in Alzheimer-type dementia.

AB - Some reports have suggested that naloxone, a short-acting opiate receptor blocker given intravenously, has a beneficial effect on the symptoms of senile dementia of the Alzheimier type. We have performed a double-blind, crossover trial of naltrexone, an orally active, long acting opiate antagonist, in 17 Alzheimer-type dementia patients. None showed any improvement in assessments of day-to-day living skills or on a battery of neuropsychological tests. No side effects were noted. In the dosage used, naltrexone appears not to be useful in Alzheimer-type dementia.

UR - http://www.scopus.com/inward/record.url?scp=0022398152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022398152&partnerID=8YFLogxK

U2 - 10.1136/jnnp.48.11.1169

DO - 10.1136/jnnp.48.11.1169

M3 - Article

C2 - 3001233

AN - SCOPUS:0022398152

VL - 48

SP - 1169

EP - 1171

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

SN - 0022-3050

IS - 11

ER -